Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-18

Clinical Trial Update: Testing Doxazosin to Treat Stress Mechanisms in Alcoholism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on doxazosin for stress mechanisms in alcoholism has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Alcoholism | Phase 2 | Status: COMPLETED | Results posted: 2021-03-18